Stay updated on Safety of Sotatercept in Beta-Thalassemia Clinical Trial
Sign up to get notified when there's something new on the Safety of Sotatercept in Beta-Thalassemia Clinical Trial page.

Latest updates to the Safety of Sotatercept in Beta-Thalassemia Clinical Trial page
- Check4 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedA site-wide notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” It appears above the unavailable study record.SummaryDifference1%

- Check18 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2; the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check25 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page otherwise remains a 403 Forbidden error page.SummaryDifference0.2%

- Check46 days agoChange DetectedA 403 Forbidden error page now appears in place of the study record, indicating restricted access to the content. This represents an access issue rather than any change to the study details on the page.SummaryDifference19%

- Check67 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a newer page version without substantive content changes.SummaryDifference0.0%

Stay in the know with updates to Safety of Sotatercept in Beta-Thalassemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Sotatercept in Beta-Thalassemia Clinical Trial page.